Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aclaris Therapeutics

1.56
+0.03001.96%
Post-market: 1.53-0.0300-1.92%19:15 EDT
Volume:666.22K
Turnover:1.02M
Market Cap:168.92M
PE:-1.08
High:1.56
Open:1.53
Low:1.50
Close:1.53
Loading ...
Feb 05, 2024

Major Issues Report

Form 8-K - Current report
Feb 05, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 01, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Major Issues Report

Form 8-K - Current report
Jan 16, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 11, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 25, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 24, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2023

Major Issues Report

Form 8-K - Current report
Sep 05, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Major Issues Report

Form 8-K - Current report